Partnering

Shaping the future of healthcare
Rapid advances in information technology are driving significant changes in how healthcare is provided. For example, the foundations are being laid for the delivery of personalized treatment through aggregation and analysis of big data on individual patient health profiles. New systems are also being worked out to allow patients to receive medical examinations and guidance on drug compliance without having to visit a medical facility and for pharmaceuticals to be delivered directly to the patient’s home. Shionogi is responding to these changes and working to build healthcare platforms, creating value with partners that have complementary capabilities and aligned visions for the future of healthcare, as part of the Company’s goal of developing HaaS to shape the future of healthcare.

Strategic alliances geared toward sustained growth after 2020
Strategic Business Investments
![[Infectious Disease] Drug candidates for mycobacterial diseases (Hsiri Therapeutics), Research collaboration on anti-RS virus agent (Ube Industries), Collaborative research on prophylaxis and treatment of malaria(Nagasaki University), Nitric oxide inhaled antimicrobial drug candidates (Vast Therapeutics), Technology for antimicrobial resistance (Nemesis Bioscience) → Research on the 3 major infectious diseases (HIV, Tuberculosis, Malaria) and refractory infectious diseases: Establish Shionogi’s presence in infectious diseases globally [Pain CNC] Antidepressant candidate S-812217(Sage Therapeutics), Drug candidate for cognitive and memory deficits BPN-14770(Tetra Discovery Partners), Digital therapeutics AKL-T01, AKL-T02(Akili Interactive) → Expanding into wider range of treatment options: Provide new treatment options with novel mechanisms [Modality] PDC technology (PeptiDream), Regenerative medicine product candidate ADR-001 (Rohto Pharmaceutical) → Acquiring new modalities: Solve unmet needs that cannot be met with small molecule drug](/content/dam/shionogi/global/innovation/partnering/images/partnering-img-03.png)